Raptor Pharmaceuticals (RPTP): Q4 EPS of -$0.37 misses by $0.10. (PR)

Raptor Pharmaceuticals (RPTP): Q4 EPS of -$0.37 misses by $0.10. (PR)
Comments (1)
  • pudia
    , contributor
    Comment (1) | Send Message
    whoever wrote this headline has made an embarrassing mistake. . Raptor is changing from an August fiscal year to a normal calendar year and had to report results for the four months september 2012 though december 2012, a a 4 month period for which no analysts have published estimates. how could the company have missed when there were no published estimates? A normal quarter is 3 months and this was a period of four months. this story should be removed.
    15 Mar 2013, 05:27 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs